Skip to main content

Expression of midkine and endoglin in breast carcinomas with different immunohistochemical profiles

Buy Article:

$43.00 plus tax (Refund Policy)

Li LQ, Huang HL, Ping JL, Xu W, Li J, Dai LC. Expression of midkine and endoglin in breast carcinomas with different immunohistochemical profiles, APMIS 2010; 119: 103–110.

The aim of this study was to investigate the midkine and endoglin expression in breast carcinomas with five different immunohistochemical profiles and their relevance to histopathologic and clinicopathologic features. We analyzed 161 archival tissues immunohistologically. The level of midkine expression in breast cancer significantly correlated with lymph node metastasis (p = 0.001) and TNM staging (p = 0.003). High microvessel density (MVD) was associated with higher midkine reactivity group (p = 0.036). Although the basal-like subtype had higher midkine expression level and MVD, no significant difference with the other breast cancer subtypes was found. In conclusion, midkine was a promising target for tumor prognosis in clinical diagnosis and treatment. This study found no significant differences in tumor angiogenesis in different molecular subtypes of breast cancer.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Basal-like subtype; breast carcinoma; endoglin; immunohistochemistry; midkine

Document Type: Research Article

Affiliations: 1: Huzhou Key Laboratory of Molecular Medicine 2: Department of Pathology, Affiliated Central Hospital of Huzhou Teachers College, Huzhou, Zhejiang, China

Publication date: 2011-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more